These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 15849463

  • 1. Feasibility of hepatocyte transplantation-based therapies for primary hyperoxalurias.
    Guha C, Yamanouchi K, Jiang J, Wang X, Roy Chowdhury N, Santana A, Shapiro LJ, Salido E, Roy-Chowdhury J.
    Am J Nephrol; 2005; 25(2):161-70. PubMed ID: 15849463
    [Abstract] [Full Text] [Related]

  • 2. Correction of hyperoxaluria by liver repopulation with hepatocytes in a mouse model of primary hyperoxaluria type-1.
    Jiang J, Salido EC, Guha C, Wang X, Moitra R, Liu L, Roy-Chowdhury J, Roy-Chowdhury N.
    Transplantation; 2008 May 15; 85(9):1253-60. PubMed ID: 18475180
    [Abstract] [Full Text] [Related]

  • 3. The primary hyperoxalurias.
    Bobrowski AE, Langman CB.
    Semin Nephrol; 2008 Mar 15; 28(2):152-62. PubMed ID: 18359396
    [Abstract] [Full Text] [Related]

  • 4. [Primary hyperoxaluria].
    Cochat P, Fargue S, Bacchetta J, Bertholet-Thomas A, Sabot JF, Harambat J.
    Nephrol Ther; 2011 Jul 15; 7(4):249-59. PubMed ID: 21636340
    [Abstract] [Full Text] [Related]

  • 5. Selective repopulation of mice liver after Fas-resistant hepatocyte transplantation.
    Fujino M, Li XK, Kitazawa Y, Funeshima N, Guo L, Okuyama T, Amano T, Amemiya H, Suzuki S.
    Cell Transplant; 2001 Jul 15; 10(4-5):353-61. PubMed ID: 11549054
    [Abstract] [Full Text] [Related]

  • 6. Auxiliary liver organ formation by implantation of spleen-encapsulated hepatocytes.
    Nishio R, Nakayama M, Ikekita M, Watanabe Y.
    Tissue Eng; 2006 Sep 15; 12(9):2565-72. PubMed ID: 16995789
    [Abstract] [Full Text] [Related]

  • 7. [Primary hyperoxaluria].
    Toussaint C, De Pauw L.
    Nephrologie; 1995 Sep 15; 16(6):399-406. PubMed ID: 8524446
    [Abstract] [Full Text] [Related]

  • 8. Hepatocyte transplantation from steatotic liver in a rat model.
    Hayashi K, Aoki T, Jin Z, Wang H, Nishino N, Kusano T, Yasuda D, Koizumi T, Enami Y, Odaira M, Yamada K, Mitamura K, Niiya T, Murai N, Kato H, Shimizu Y, Kusano M.
    J Surg Res; 2007 Sep 15; 142(1):104-12. PubMed ID: 17604052
    [Abstract] [Full Text] [Related]

  • 9. Primary hyperoxaluria: clinical course, diagnosis, and treatment after kidney failure.
    Raju DL, Cantarovich M, Brisson ML, Tchervenkov J, Lipman ML.
    Am J Kidney Dis; 2008 Jan 15; 51(1):e1-5. PubMed ID: 18155525
    [Abstract] [Full Text] [Related]

  • 10. Regional transient portal ischemia and irradiation as preparative regimen for hepatocyte transplantation.
    Koenig S, Yuan Q, Krause P, Christiansen H, Rave-Fraenk M, Kafert-Kasting S, Kriegbaum H, Schneider A, Ott M, Meyburg J.
    Cell Transplant; 2011 Jan 15; 20(2):303-11. PubMed ID: 20719089
    [Abstract] [Full Text] [Related]

  • 11. Successful in vivo propagation of factor IX-producing hepatocytes in mice: potential for cell-based therapy in haemophilia B.
    Tatsumi K, Ohashi K, Kataoka M, Tateno C, Shibata M, Naka H, Shima M, Hisanaga M, Kanehiro H, Okano T, Yoshizato K, Nakajima Y, Yoshioka A.
    Thromb Haemost; 2008 May 15; 99(5):883-91. PubMed ID: 18449417
    [Abstract] [Full Text] [Related]

  • 12. The primary hyperoxalurias: an algorithm for diagnosis.
    Milliner DS.
    Am J Nephrol; 2005 May 15; 25(2):154-60. PubMed ID: 15855742
    [Abstract] [Full Text] [Related]

  • 13. Efficient hepatocyte engraftment in a nonhuman primate model after partial portal vein embolization.
    Dagher I, Boudechiche L, Branger J, Coulomb-Lhermine A, Parouchev A, Sentilhes L, Lin T, Groyer-Picard MT, Vons C, Hadchouel M, Pariente D, Andreoletti M, Franco D, Weber A.
    Transplantation; 2006 Oct 27; 82(8):1067-73. PubMed ID: 17060856
    [Abstract] [Full Text] [Related]

  • 14. Liver repopulation and long-term function of rat small hepatocyte transplantation as an alternative cell source for hepatocyte transplantation.
    Shibata C, Mizuguchi T, Kikkawa Y, Nobuoka T, Oshima H, Kawasaki H, Kawamoto M, Katsuramaki T, Mitaka T, Hirata K.
    Liver Transpl; 2006 Jan 27; 12(1):78-87. PubMed ID: 16382477
    [Abstract] [Full Text] [Related]

  • 15. A 20-year experience of combined liver/kidney transplantation for primary hyperoxaluria (PH1): the European PH1 transplant registry experience 1984-2004.
    Jamieson NV, European PHI Transplantation Study Group.
    Am J Nephrol; 2005 Jan 27; 25(3):282-9. PubMed ID: 15961948
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte transplantation through the hepatic vein: a new route of cell transplantation to the liver.
    Goto Y, Ohashi K, Utoh R, Yamamoto M, Okano T.
    Cell Transplant; 2011 Jan 27; 20(8):1259-70. PubMed ID: 21176398
    [Abstract] [Full Text] [Related]

  • 17. Human hepatocyte transplantation: state of the art.
    Fitzpatrick E, Mitry RR, Dhawan A.
    J Intern Med; 2009 Oct 27; 266(4):339-57. PubMed ID: 19765179
    [Abstract] [Full Text] [Related]

  • 18. External-beam radiotherapy as preparative regimen for hepatocyte transplantation after partial hepatectomy.
    Christiansen H, Koenig S, Krause P, Hermann RM, Rave-Frank M, Proehl T, Becker H, Hess CF, Schmidberger H.
    Int J Radiat Oncol Biol Phys; 2006 Jun 01; 65(2):509-16. PubMed ID: 16690433
    [Abstract] [Full Text] [Related]

  • 19. Human hepatoma HepaRG cell line engraftment in severe combined immunodeficient × beige mice using mouse-specific anti-Fas antibody.
    Jiang L, Li JG, Lan L, Wang YM, Mao Q, You JP.
    Transplant Proc; 2010 Nov 01; 42(9):3773-8. PubMed ID: 21094855
    [Abstract] [Full Text] [Related]

  • 20. Potential for bilateral nephrectomy to reduce oxalate release after combined liver and kidney transplantation for primary hyperoxaluria type 1.
    Mizusawa Y, Parnham AP, Falk MC, Burke JR, Nicol D, Yamanaka J, Lynch SV, Strong RW.
    Clin Transplant; 1997 Oct 01; 11(5 Pt 1):361-5. PubMed ID: 9361924
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.